Skip to content

Silgan Holdings SLGN Operating Income

Discontinued — last reported Q4 '17

Operating Income at other companies

Sonoco Products logo
Sonoco ProductsSON
$127.09M+0.2%
AptarGroup logo
AptarGroupATR
$107.5M-5.2%
Crown Holdings logo
Crown HoldingsCCK
$365M0.0%
Amcor logo
AmcorAMCR
$461M+47.3%
AVT
AvantorAVTR
$99.5M-32.5%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$177.1M+65.5%

Other financials

Income statement

See full
Revenue$1.6B+6.4%
Gross profit$265.8M-1.7%
Net income$63.0M-7.2%
EPS (diluted)$0.60-4.8%

Balance sheet

See full
Cash & equivalents$435.4M+23.3%
Total debt$5.7B-2.1%
Total equity$2.3B+11.4%
Total assets$9.3B+6.3%

Cash flow

See full
Operating cash flow-$799.6M-17.0%
CapEx$82.4M-0.6%
Free cash flow-$882.0M-15.1%

Valuation

See full
Market cap$4.4B-25.1%
Enterprise value$9.63B-14.4%
P/E15.5×-4.8×
P/S0.7×-0.3×

Profitability

See full
Gross margin17.4%-0.2pp
Operating margin8.7%
Net margin4.3%-0.5pp
FCF margin4.7%-0.6pp

Returns & leverage

See full
Return on equity12.9%-1.6pp
Debt / equity2.4×-0.3×
Current ratio1.3×+0.1×

Where this comes from

Reported directly by Silgan Holdings in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Silgan Holdings’s 10-K, filed March 1, 2018, on SEC EDGAR. View the filing →

Questions, answered.

What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.